BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32071730)

  • 1. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
    Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
    J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over.
    Cavillon Decaestecker M; Ferret L; Decaestecker K; Gautier S; Verdun S; Tsogli ES
    Drugs Aging; 2021 Oct; 38(10):939-950. PubMed ID: 34486094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States.
    Sandhu A; Kaltenbach LA; Chiswell K; Shimoga V; Ashur C; Pribish A; Fonarow GC; Piccini JP; Ho PM; Varosy PD; Hess PL
    Circ Cardiovasc Qual Outcomes; 2023 Dec; 16(12):e010062. PubMed ID: 37929603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
    Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
    Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation.
    Lavoie K; Turgeon MH; Brais C; Larochelle J; Blais L; Farand P; Letemplier G; Perreault S; Beauchesne MF
    J Atr Fibrillation; 2016 Dec; 9(4):1478. PubMed ID: 29250254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing.
    Moudallel S; Steurbaut S; Cornu P; Dupont A
    Front Pharmacol; 2018; 9():1220. PubMed ID: 30425641
    [No Abstract]   [Full Text] [Related]  

  • 7. Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation.
    Li RJ; Caughey GE; Shakib S
    J Thromb Thrombolysis; 2022 Feb; 53(2):425-435. PubMed ID: 34302286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF.
    Guenoun M; Cohen S; Villaceque M; Sharareh A; Schwartz J; Hoffman O; Dib JC; Ouazana L; Assouline S; Parrens E; Garban T; Pradeau V; Guedj-Meynier D; Lequeux B; Cohen C; Durand P; Dievart F; Dhanjal TS; Sabouret P; Lellouche N
    Europace; 2023 Oct; 25(10):. PubMed ID: 37801642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants for under- and overdosing of direct oral anticoagulants and physicians' implementation of clinical pharmacists' recommendations.
    Moudallel S; Cornu P; Dupont A; Steurbaut S
    Br J Clin Pharmacol; 2022 Feb; 88(2):753-763. PubMed ID: 34331720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
    Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
    JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
    Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
    Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial Fibrillation.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Peterson GM
    J Patient Saf; 2022 Jun; 18(4):337-341. PubMed ID: 35617592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of inappropriate dosing of direct oral anticoagulants.
    Ko HTK; Pham J; Anpalahan M
    Intern Med J; 2023 Oct; 53(10):1790-1795. PubMed ID: 36448650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.
    Zhang ZX; van de Garde EMW; Söhne M; Harmsze AM; van den Broek MPH
    Br J Clin Pharmacol; 2020 Aug; 86(8):1567-1574. PubMed ID: 32090369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study.
    Feng Y; Pai CW; Seiler K; Barnes GD
    J Thromb Thrombolysis; 2021 May; 51(4):1144-1149. PubMed ID: 33389520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study.
    Sanghai S; Wong C; Wang Z; Clive P; Tran W; Waring M; Goldberg R; Hayward R; Saczynski JS; McManus DD
    J Am Heart Assoc; 2020 Mar; 9(6):e014108. PubMed ID: 32146898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
    van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
    Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey.
    Fuat A; Ako E; Hargroves D; Holden D; Caleyachetty A; Carter M; Harris J; Roberts C; Nzeakor N; Vardar B; Williams H
    J Mark Access Health Policy; 2023; 11(1):2267327. PubMed ID: 37954532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.